Company

Mylan is a global healthcare company focused on making high quality medicines available to everyone who needs them.  Our broad and diverse portfolio of more than 7,500 marketed products is available to customers of all types including retail and pharmacy establishments, wholesalers, governments, institutions and physicians.


We apply one global quality standard across our facilities and across our product line . . . regardless of market.

A History of Doing What’s Right

We began in 1961 as a company dedicated to helping people in small West Virginia towns and rural communities gain access to affordable medicine. Today, we remain dedicated to the same mission, but we do it for the world.

Looking to the Future

  1. 0

    One Quality Standard

    Medicines and their ingredients can be made in facilities all over the world. We believe in one global quality standard for all medicines. And we passionately support efforts and legislation that bring us all closer to that goal.
  2. 0

    Increasing Generic Utilization

    We’re actively educating governments around the world about the role generic medicines play in affordable health care and access to medicine.
  3. 0

    Biosimilars: Advancing our Commitment

    Mylan has a combined portfolio of 16 biosimilar and insulin analog products in development, which is one of the industry’s largest and most diverse portfolios. Biosimilars play an important role in Mylan’s commitment to setting new standards in healthcare by offering quality alternatives to more costly therapeutic options and increasing access to treatment for patients.
     

    Biosimilars are products deemed highly similar to an already FDA-approved product known as a biological reference product and have no clinically meaningful differences in terms of safety and effectiveness from the reference product. These highly complex and often expensive therapies are used in diseases like cancer, multiple sclerosis, rheumatoid arthritis and diabetes. Biosimilar development uses the latest state-of-the-art analytical and biotechnology methods, including some that may not have been available at the time the reference product was first approved. 

     

  • Our Values

    What sets us apart? Innovation, Integrity, Reliability, Service and Teamwork. Living our values is how we can work to provide 7 billion people access to high quality medicine.
    Discover how our values define us
  • Mylan Voices

    • Robert J Coury
      Chairman
      "We have one global quality standard because we know where our priorities are. It all starts and ends with you."
    • Heather Bresch
      Chief Executive Officer
      "Our mission is to provide 7 billion people access to high quality medicine.
      We are determined to put the care back in health care."
    • Rajiv Mallik
      President
      "Setting new standards in health care is a promise that Mylan keeps every day."
  • Global Manufacturing

    Our global manufacturing platform continues to grow.

    • 80 billion: Oral solid dose manufacturing capacity
    • 1.1 billion: Complex products manufacturing capacity - transdermals, dermals, topicals, respiratory, oral films and other specialty items

    • >35,000: Worldwide workforce
    • >165: Countries and territories where our products are available

    We’re also one of the world’s largest suppliers of active pharmaceutical ingredients.

Leadership

Meet our passionate global leaders.

Corporate Governance

Find governance documents, proxy information and policy statements.
  • Questions?

    Get more information on our products, services and Mylan Global Center locations.

    Contact us

  • Business Opportunities

    Do you have an opportunity or a collaboration idea?

    Partner with us